The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared with placebo in patients with overweight or obesity with or without ...

Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...

An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with ...

Among adults with episodic migraine, fasting for 5 to 6 hours a day was linked to 49% higher odds of experiencing a same-day ...

In this video, Paolo F. Caimi, MD, MBA, staff physician at Cleveland Clinic, discusses the phase 2/3 WaveLINE-003 trial of patients with relapsed/refractory diffuse B-cell lymphoma.Results of the ...

A coalition of health care organizations, called the Alliance for Healthcare from the Eye, is pushing for increased adoption ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

In this exclusive Healio Video Perspective from Kiawah Eye, P. Dee Stephenson, MD, FACS, discusses toric IOL rotation and ...

Researchers have provided more evidence that mpox virus can be passed from a pregnant mother to her child. There remain ...

Opioid overdose deaths continued to rise among adolescents and young adults during a recent 5-year period, and synthetic ...

In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix Pro, the ...